|
|
1)
|
chain |
A |
residue |
27 |
type |
|
sequence |
Y
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
2)
|
chain |
A |
residue |
28 |
type |
|
sequence |
C
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
3)
|
chain |
A |
residue |
29 |
type |
|
sequence |
G
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
4)
|
chain |
A |
residue |
30 |
type |
|
sequence |
R
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
5)
|
chain |
A |
residue |
31 |
type |
|
sequence |
G
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
6)
|
chain |
A |
residue |
48 |
type |
|
sequence |
D
|
description |
CA BINDING SITE.
|
source |
: CAA
|
|
7)
|
chain |
A |
residue |
47 |
type |
ACT_SITE |
sequence |
H
|
description |
ACT_SITE => ECO:0000305|PubMed:8419939
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
8)
|
chain |
A |
residue |
93 |
type |
ACT_SITE |
sequence |
D
|
description |
ACT_SITE => ECO:0000305|PubMed:8419939
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
9)
|
chain |
A |
residue |
29 |
type |
BINDING |
sequence |
G
|
description |
BINDING => ECO:0000269|PubMed:8419939, ECO:0007744|PDB:1PSH
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
10)
|
chain |
A |
residue |
31 |
type |
BINDING |
sequence |
G
|
description |
BINDING => ECO:0000269|PubMed:8419939, ECO:0007744|PDB:1PSH
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
11)
|
chain |
A |
residue |
48 |
type |
BINDING |
sequence |
D
|
description |
BINDING => ECO:0000269|PubMed:8419939, ECO:0007744|PDB:1PSH
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
12)
|
chain |
A |
residue |
27 |
type |
BINDING |
sequence |
Y
|
description |
BINDING => ECO:0000269|PubMed:8419939, ECO:0007744|PDB:1PSH
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
13)
|
chain |
A |
residue |
43-50 |
type |
prosite |
sequence |
CCQVHDNC
|
description |
PA2_HIS Phospholipase A2 histidine active site. CCQvHDnC
|
source |
prosite : PS00118
|
|
14)
|
chain |
A |
residue |
89-99 |
type |
prosite |
sequence |
VCDCDRLAAIC
|
description |
PA2_ASP Phospholipase A2 aspartic acid active site. VCDCDRLAaIC
|
source |
prosite : PS00119
|
|